Reactive astrocytes in Alzheimer's disease: A double-edged sword

Heejung Chun, Changjoon Lee

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is a chronic and fatal disease, in which neuronal damage at its late stage cannot be easily reversed. Because AD progression is caused by multiple factors including diverse cellular processes, studies on AD pathogenesis at the molecular and cellular level are challenging. Based on the lessons from unsuccessful neuron-focused research for an AD cure, non-cell autonomous mechanisms including brain inflammation and reactive astrocytes have recently been in the spotlight as potential therapeutic targets for AD. Studies have shown that reactive astrocytes are not only the result of inflammatory defense reactions, but also an active catabolic decomposer that acts by taking up amyloid beta toxins. Here, we give an overview of the characteristics of reactive astrocytes as pathological features of AD. Reactive astrocytes exert biphasic effects, that is, beneficial or detrimental depending on multiple factors. Many efforts have been put forth for defining and characterizing molecular signatures for the beneficial and detrimental reactive astrocytes. In the foreseeable future, manipulating and targeting each established molecular signature should have profound therapeutic implications for the treatment of AD.

Original languageEnglish
JournalNeuroscience Research
DOIs
Publication statusAccepted/In press - 2017 Jan 1
Externally publishedYes

Fingerprint

Astrocytes
Alzheimer Disease
Encephalitis
Amyloid
Disease Progression
Chronic Disease
Neurons
Therapeutics
Research

Keywords

  • Alzheimer's disease
  • Brain inflammation
  • Reactive astrocytes

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Reactive astrocytes in Alzheimer's disease : A double-edged sword. / Chun, Heejung; Lee, Changjoon.

In: Neuroscience Research, 01.01.2017.

Research output: Contribution to journalArticle

@article{a47d61bb67db40da963ba16fc094a90b,
title = "Reactive astrocytes in Alzheimer's disease: A double-edged sword",
abstract = "Alzheimer's disease (AD) is a chronic and fatal disease, in which neuronal damage at its late stage cannot be easily reversed. Because AD progression is caused by multiple factors including diverse cellular processes, studies on AD pathogenesis at the molecular and cellular level are challenging. Based on the lessons from unsuccessful neuron-focused research for an AD cure, non-cell autonomous mechanisms including brain inflammation and reactive astrocytes have recently been in the spotlight as potential therapeutic targets for AD. Studies have shown that reactive astrocytes are not only the result of inflammatory defense reactions, but also an active catabolic decomposer that acts by taking up amyloid beta toxins. Here, we give an overview of the characteristics of reactive astrocytes as pathological features of AD. Reactive astrocytes exert biphasic effects, that is, beneficial or detrimental depending on multiple factors. Many efforts have been put forth for defining and characterizing molecular signatures for the beneficial and detrimental reactive astrocytes. In the foreseeable future, manipulating and targeting each established molecular signature should have profound therapeutic implications for the treatment of AD.",
keywords = "Alzheimer's disease, Brain inflammation, Reactive astrocytes",
author = "Heejung Chun and Changjoon Lee",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.neures.2017.11.012",
language = "English",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Reactive astrocytes in Alzheimer's disease

T2 - A double-edged sword

AU - Chun, Heejung

AU - Lee, Changjoon

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Alzheimer's disease (AD) is a chronic and fatal disease, in which neuronal damage at its late stage cannot be easily reversed. Because AD progression is caused by multiple factors including diverse cellular processes, studies on AD pathogenesis at the molecular and cellular level are challenging. Based on the lessons from unsuccessful neuron-focused research for an AD cure, non-cell autonomous mechanisms including brain inflammation and reactive astrocytes have recently been in the spotlight as potential therapeutic targets for AD. Studies have shown that reactive astrocytes are not only the result of inflammatory defense reactions, but also an active catabolic decomposer that acts by taking up amyloid beta toxins. Here, we give an overview of the characteristics of reactive astrocytes as pathological features of AD. Reactive astrocytes exert biphasic effects, that is, beneficial or detrimental depending on multiple factors. Many efforts have been put forth for defining and characterizing molecular signatures for the beneficial and detrimental reactive astrocytes. In the foreseeable future, manipulating and targeting each established molecular signature should have profound therapeutic implications for the treatment of AD.

AB - Alzheimer's disease (AD) is a chronic and fatal disease, in which neuronal damage at its late stage cannot be easily reversed. Because AD progression is caused by multiple factors including diverse cellular processes, studies on AD pathogenesis at the molecular and cellular level are challenging. Based on the lessons from unsuccessful neuron-focused research for an AD cure, non-cell autonomous mechanisms including brain inflammation and reactive astrocytes have recently been in the spotlight as potential therapeutic targets for AD. Studies have shown that reactive astrocytes are not only the result of inflammatory defense reactions, but also an active catabolic decomposer that acts by taking up amyloid beta toxins. Here, we give an overview of the characteristics of reactive astrocytes as pathological features of AD. Reactive astrocytes exert biphasic effects, that is, beneficial or detrimental depending on multiple factors. Many efforts have been put forth for defining and characterizing molecular signatures for the beneficial and detrimental reactive astrocytes. In the foreseeable future, manipulating and targeting each established molecular signature should have profound therapeutic implications for the treatment of AD.

KW - Alzheimer's disease

KW - Brain inflammation

KW - Reactive astrocytes

UR - http://www.scopus.com/inward/record.url?scp=85037735178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037735178&partnerID=8YFLogxK

U2 - 10.1016/j.neures.2017.11.012

DO - 10.1016/j.neures.2017.11.012

M3 - Article

C2 - 29225140

AN - SCOPUS:85037735178

JO - Neuroscience Research

JF - Neuroscience Research

SN - 0168-0102

ER -